Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 86.60% is in line with its 5-year average of 81.51%, near the high end of its 5-year range (70.77%–87.39%).
0.88% above its 12-month average of 85.84%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 87.39%.
GROSS MARGIN
86.60%
GROSS MARGIN AVG TTM
85.84%
GROSS MARGIN AVG 3Y
84.63%
GROSS MARGIN AVG 5Y
81.51%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+0.88%
CURRENT VS 3Y AVG
+2.33%
CURRENT VS 5Y AVG
+6.24%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.32%
median of 765 covered companies
CURRENT VS SECTOR MEDIAN
+114.78%
vs the sector median at left
Market Cap
$44.31M
Gross Margin
22.65%
TTM Avg
11.13%
3Y Avg
-12.99%
5Y Avg
-22.58%
Market Cap
$45.20M
Gross Margin
56.09%
TTM Avg
52.85%
3Y Avg
42.50%
5Y Avg
40.42%
Market Cap
$45.42M
Gross Margin
0.00%
TTM Avg
1.89%
3Y Avg
44.91%
5Y Avg
29.94%
Market Cap
$43.83M
Gross Margin
-98.21%
TTM Avg
-96.12%
3Y Avg
-84.75%
5Y Avg
-75.83%
Market Cap
$43.04M
Gross Margin
75.20%
TTM Avg
76.17%
3Y Avg
74.22%
5Y Avg
71.65%
Market Cap
$42.97M
Gross Margin
93.13%
TTM Avg
94.29%
3Y Avg
92.05%
5Y Avg
80.64%
Market Cap
$47.83M
Gross Margin
17.22%
TTM Avg
17.52%
3Y Avg
25.54%
5Y Avg
27.62%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CVRx, Inc. (CVRX) | $44.60M | 86.60% | 85.84% | 84.63% | 81.51% |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $44.31M | 22.65% | 11.13% | -12.99% | -22.58% |
| DarioHealth Corp. (DRIO)vs › | $45.20M | 56.09% | 52.85% | 42.50% | 40.42% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.42M | 0.00% | 1.89% | 44.91% | 29.94% |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.83M | -98.21% | -96.12% | -84.75% | -75.83% |
| SANUWAVE Health Inc. (SNWV)vs › | $43.04M | 75.20% | 76.17% | 74.22% | 71.65% |
| BioStem Technologies, Inc. (BSEM)vs › | $42.97M | 93.13% | 94.29% | 92.05% | 80.64% |
| Precipio, Inc. (PRPO)vs › | $41.92M | 43.69% | 45.94% | 39.54% | 34.01% |
| Precision Optics Corporation, Inc. (POCI)vs › | $47.83M | 17.22% | 17.52% | 25.54% | 27.62% |
| Lite Strategy, Inc. (LITS)vs › | $48.83M | 0.00% | 0.00% | 50.00% | 65.99% |
Gross Margin
86.6%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 87.39% |
| 2026-03-31 | 87.22% |
| 2025-12-31 | 86.28% |
| 2025-09-30 | 85.49% |
| 2025-06-30 | 82.84% |
| 2025-03-31 | 83.51% |
| 2024-12-31 | 85.01% |
| 2024-09-30 | 83.19% |
| 2024-06-30 | 82.71% |
| 2024-03-31 | 83.79% |
| 2023-12-31 | 84.79% |
| 2023-09-30 | 83.91% |
| 2023-06-30 | 84.03% |
| 2023-03-31 | 83.36% |
| 2022-12-31 | 78.97% |
| 2022-09-30 | 78.34% |
| 2022-06-30 | 76.13% |
| 2022-03-31 | 76.72% |
| 2021-12-31 | 73.10% |
| 2021-09-30 | 74.20% |
| 2021-06-30 | 70.77% |
| 2021-03-31 | 69.69% |
| 2020-12-31 | 78.40% |
| 2020-09-30 | 78.74% |
| 2020-06-30 | 72.40% |
| 2020-03-31 | 74.85% |
